Navigation Links
Diagenode licenses new ChIPmentation technology for low input library preparation for ChIP-sequencing
Date:6/14/2017

Liège, Belgium (PRWEB) June 14, 2017 -- Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has licensed a new technology specific for ChIP-sequencing from the CeMM for low input samples.

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) allows the study of histone modifications and transcription factor binding on a genome-wide scale. However, ChIP from low input, biologically-relevant samples is challenging. Researchers in Christoph Bock’s group at CeMM have developed an efficient alternative to ChIP-seq that addresses these limitations, which they have coined “ChIPmentation.”

In ChIPmentation, ChIP and library preparation for sequencing can be accomplished concurrently using a transposase, that allows the incorporation of sequencing adaptors on the immunoprecipitated chromatin directly. This approach streamlines the ChIP-seq workflow to make the study of chromatin from rare and difficult cell types possible. The lab’s work was published in Nature Methods article “ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors.”

Diagenode’s license terms with the CeMM include acquiring quality procedures and expertise for ChIPmentation libraries and sequencing as well as bioinformatics analysis know-how.

“Our license agreement with the CeMM for ChIPmentation will bring ChIP-seq to new frontiers and reinforces our commitment to furthering epigenetics research,” said Didier Allaer, CEO of Diagenode. “We will be incorporating the ChIPmentation technology into Diagenode’s Epigenomic Profiling Services upon launch later this year. Researchers will finally be able to address epigenetics profiling with difficult samples, biopsies, and other patient-derived samples.”
In addition, the company is developing an automated library preparation method using ChIPmentation on its signature automation instrument the IP-Star? Compact Automated System. This strategy further streamlines ChIP-seq by incorporating ChIP and library preparation more effectively and efficiently.

“We are very excited about our collaboration with Diagenode,” said Christoph Bock of the CeMM. “Diagenode has a long history of proficiency in developing innovative technologies for epigenetics research.”

To learn more about ChIPmentation and stay informed about the release of this technology from Diagenode, please visit https://diagenode.typeform.com/to/eFXflf. To learn more about Diagenode, please visit http://www.diagenode.com.

About Diagenode:
Diagenode is a leading provider of complete solutions for epigenetics research and sample preparation. The company has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative DNA and chromatin shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include the industry’s most validated ChIP antibodies, CATS-based RNA sequencing, and epigenetics assay services. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14390486.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Diagenode Introduces Innovative Bioruptor® Pico for Micro-Volume Chromatin and DNA Shearing
2. Diagenode Launches Novel CRISPR/Cas9 Monoclonal Antibody
3. Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation
4. Diagenode launches a complete portfolio for bisulfite sequencing solutions
5. Diagenode Announces New Collaboration to Develop a High-Sensitivity DNA Amplification Method for Sequencing
6. SRI International Licenses Bed Bug Detection Technology to Redcoat, a Virginia-Based Start-Up Company
7. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
8. Genomatica Licenses TeselaGen Software for DNA Design
9. Sigma Life Science Licenses CompoZr Zinc Finger Nuclease Technology to Horizon Discovery
10. SAGE Labs, Inc. Licenses CRISPR/Cas9 genome engineering technology from Caribou Biosciences, Inc.
11. FDA, EMA Extend Licenses for Aptiv Solutions ADDPLAN® Software for Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... , ... June 20, 2017 , ... ... immediately determine the adulterants which pose the most likely threat to their products ... of this year. , IFT's annual food expo attracts over 20,000 attendees ...
(Date:6/19/2017)... ... June 19, 2017 , ... As Vice President, ... products including training, implementation, support, and client process and SOP development. , Mr. ... previously held leadership roles for service providers and top-tier pharmaceuticals, and as an ...
(Date:6/16/2017)... ... June 16, 2017 , ... ... analytics solutions, today announced that its Anzo Smart Data Lake® (Anzo SDL) ... Solution’ category for the 2017 Software & Information Industry Association (SIIA) CODiE Awards. ...
(Date:6/15/2017)... ... June 15, 2017 , ... ... promising new medical device startup. Dan Parsley, angelMD’s SVP of Corporate Development, served ... and this angelMD syndicate is part of Saranas’ recently announced $4 million Series ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
Breaking Biology News(10 mins):